MindWalk Holdings (HYFT) Non-Current Deferred Tax Liability (2020 - 2025)
MindWalk Holdings (HYFT) reported Non-Current Deferred Tax Liability of $175682.2 for Q2 2025, down 94.14% year-over-year from $3.0 million in Q2 2024, and up 4.79% quarter-over-quarter from $167653.6 in Q1 2025.
MindWalk Holdings (HYFT) Non-Current Deferred Tax Liability (2020 - 2025) Analysis & Trends
MindWalk Holdings (HYFT) has 6 years of Non-Current Deferred Tax Liability data on file, last reported at $175682.2 in Q2 2025.
- Non-Current Deferred Tax Liability for Q2 2025 came in at $175682.2, down 94.14% year-over-year; the trailing twelve-month figure through Apr 2025 was $175682.2 (down 94.14% YoY), and the FY2025 annual result was $179471.8, down 94.02% from the prior year.
- Non-Current Deferred Tax Liability climbed to $175682.2 in Q2 2025 per HYFT's latest filing, from $167653.6 in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $6.4 million in Q2 2022 and troughed at $167653.6 in Q1 2025.
- A 5-year average of $3.3 million and a median of $2.7 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
- The sharpest annual moves came in 2023 and 2025: Non-Current Deferred Tax Liability soared 595.25% in 2023, then slumped 96.71% in 2025.
- A 5-year view of Non-Current Deferred Tax Liability shows it stood at $956911.6 in 2021, then soared by 504.18% to $5.8 million in 2022, then retreated by 8.88% to $5.3 million in 2023, then sank by 55.41% to $2.3 million in 2024, then slumped by 92.52% to $175682.2 in 2025.
- Business Quant data shows HYFT's Non-Current Deferred Tax Liability at $175682.2 in Q2 2025, $167653.6 in Q1 2025, and $2.3 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | 175,682.17 |
| Apr 30, 2025 | 175,682.17 |
| Jan 31, 2025 | 167,653.59 |
| Jan 31, 2025 | 167,653.59 |
| Oct 31, 2024 | 2.35 Mn |
| Oct 31, 2024 | 2.35 Mn |
| Jul 31, 2024 | 2.47 Mn |
| Jul 31, 2024 | 2.47 Mn |
| Apr 30, 2024 | 3.00 Mn |
| Apr 30, 2024 | 3.00 Mn |
| Jan 31, 2024 | 5.09 Mn |
| Jan 31, 2024 | 5.09 Mn |
| Oct 31, 2023 | 5.27 Mn |
| Oct 31, 2023 | 5.27 Mn |
| Jul 31, 2023 | 5.45 Mn |
| Jul 31, 2023 | 5.45 Mn |
| Apr 30, 2023 | 5.66 Mn |
| Apr 30, 2023 | 5.66 Mn |
| Jan 31, 2023 | 5.92 Mn |
| Jan 31, 2023 | 5.92 Mn |